Attached files

file filename
10-K - 10-K - INCYTE CORPincy-20171231x10k.htm
EX-32.2 - EX-32.2 - INCYTE CORPincy-20171231ex3220a4b41.htm
EX-32.1 - EX-32.1 - INCYTE CORPincy-20171231ex321708576.htm
EX-31.2 - EX-31.2 - INCYTE CORPincy-20171231ex3126dab14.htm
EX-31.1 - EX-31.1 - INCYTE CORPincy-20171231ex311c609d4.htm
EX-21.1 - EX-21.1 - INCYTE CORPincy-20171231ex2112d7652.htm
EX-12.1 - EX-12.1 - INCYTE CORPincy-20171231ex12101ef1c.htm
EX-10.23 - EX-10.23 - INCYTE CORPincy-20171231ex10239cab7.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements: (Form S-3 No. 333-209694) of Incyte Corporation, (Form S-8 Nos. 333-91556, 333-125995, and 333-160006) pertaining to the 1993 Directors’ Stock Option Plan of Incyte Corporation, (Form S-8 No. 333-160005) pertaining to the 1991 Stock Plan of Incyte Corporation, (Form S-8 Nos. 333-174919 and 333-212102) pertaining to the 1997 Employee Stock Purchase Plan of Incyte Corporation, (Form S-8 Nos. 333-174918, 333-182218, 333-189424, 333-197907, and 333-212104) pertaining to the 2010 Stock Incentive Plan of Incyte Corporation, (Form S-8 No. 333-193333) pertaining to the 2014 Restricted Stock Unit Award Agreement between Incyte Corporation and Hervé Hoppenot, as applicable, of our reports dated February 15, 2018, with respect to the consolidated financial statements of Incyte Corporation and the effectiveness of internal control over financial reporting of Incyte Corporation, included in this Annual Report (Form 10-K) for the year ended December 31, 2017.

 

 

 

/s/ Ernst & Young LLP

 

 

Philadelphia, Pennsylvania

February 15, 2018